Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Construction in Progress (2016 - 2019)

Historic Construction in Progress for Lineage Cell Therapeutics (LCTX) over the last 6 years, with Q1 2019 value amounting to $8.9 million.

  • Lineage Cell Therapeutics' Construction in Progress changed N/A to $8.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2018, which is 7708.3% down from last year.
  • Lineage Cell Therapeutics' Construction in Progress amounted to $8.9 million in Q1 2019.
  • Lineage Cell Therapeutics' 5-year Construction in Progress high stood at $8.9 million for Q1 2019, and its period low was $93000.0 during Q4 2015.
  • In the last 5 years, Lineage Cell Therapeutics' Construction in Progress had a median value of $1.6 million in 2016 and averaged $3.1 million.
  • Its Construction in Progress has fluctuated over the past 5 years, first tumbled by 7709.36% in 2015, then soared by 11726.19% in 2016.
  • Lineage Cell Therapeutics' Construction in Progress (Quarter) stood at $93000.0 in 2015, then soared by 1620.43% to $1.6 million in 2016, then soared by 245.81% to $5.5 million in 2017, then crashed by 77.08% to $1.3 million in 2018, then surged by 603.31% to $8.9 million in 2019.
  • Its Construction in Progress stands at $8.9 million for Q1 2019, versus $1.3 million for Q4 2018 and $5.1 million for Q3 2018.